Tags

Type your tag names separated by a space and hit enter

The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
J Cell Biochem. 2007 Oct 01; 102(2):377-88.JC

Abstract

Green tea has been reported as potential dietary protection against numerous cancers and has been shown to have activity in bladder tumor inhibition in different animal models. The goal of this study was to examine the effects of (-)-epigallocatechin gallate (EGCG-the major phytochemical in green tea) on growth inhibition and behavior of human bladder carcinoma cells and to identify the altered signaling pathway(s) underlying the response to EGCG exposure. EGCG inhibited the in vitro growth of invasive bladder carcinoma cells with an IC(50) range of 70-87 microM. At a concentration of 20 microM, EGCG decreased the migratory potential of bladder carcinoma cells with concomitant activation of p42/44 MAPK and STAT3 and inactivation of Akt. Using biochemical inhibitors of MAPK/ERK, and siRNA to knockdown STAT3 and Akt, inhibition of migration was recorded associated with Akt but not MAPK/ERK or STAT3 signaling in bladder cells. In addition, EGCG downregulated N-cadherin in a dose-dependent manner where reduction in N-cadherin expression paralleled declining migratory potential. Continuous feeding of EGCG to mice prior to and during the establishment of bladder carcinoma xenografts in vivo revealed >50% reduction in mean final tumor volume (P </= 0.05) with no detectable toxicity. EGCG inhibited bladder carcinoma cell growth and suppressed the in vitro migration capacity of cells via downregulation of N-cadherin and inactivation of Akt signaling. Continuous administration of EGCG to mice revealed significant inhibition of tumor growth in vivo indicating a possible preventative role for green tea in bladder cancer.

Authors+Show Affiliations

Cell and Molecular Biology Laboratory, Robert E. Wise Research and Education Institute, Lahey Clinic Medical Center, 31 Mall Road, Burlington, Massachusetts 01805, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17348027

Citation

Rieger-Christ, Kimberly M., et al. "The Green Tea Compound, (-)-epigallocatechin-3-gallate Downregulates N-cadherin and Suppresses Migration of Bladder Carcinoma Cells." Journal of Cellular Biochemistry, vol. 102, no. 2, 2007, pp. 377-88.
Rieger-Christ KM, Hanley R, Lodowsky C, et al. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. J Cell Biochem. 2007;102(2):377-88.
Rieger-Christ, K. M., Hanley, R., Lodowsky, C., Bernier, T., Vemulapalli, P., Roth, M., Kim, J., Yee, A. S., Le, S. M., Marie, P. J., Libertino, J. A., & Summerhayes, I. C. (2007). The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. Journal of Cellular Biochemistry, 102(2), 377-88.
Rieger-Christ KM, et al. The Green Tea Compound, (-)-epigallocatechin-3-gallate Downregulates N-cadherin and Suppresses Migration of Bladder Carcinoma Cells. J Cell Biochem. 2007 Oct 1;102(2):377-88. PubMed PMID: 17348027.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells. AU - Rieger-Christ,Kimberly M, AU - Hanley,Robert, AU - Lodowsky,Christopher, AU - Bernier,Trisha, AU - Vemulapalli,Praneeth, AU - Roth,Mendel, AU - Kim,Jiyoung, AU - Yee,Amy S, AU - Le,Sandrine Meé, AU - Marie,Pierre J, AU - Libertino,John A, AU - Summerhayes,Ian C, PY - 2007/3/10/pubmed PY - 2008/3/29/medline PY - 2007/3/10/entrez SP - 377 EP - 88 JF - Journal of cellular biochemistry JO - J Cell Biochem VL - 102 IS - 2 N2 - Green tea has been reported as potential dietary protection against numerous cancers and has been shown to have activity in bladder tumor inhibition in different animal models. The goal of this study was to examine the effects of (-)-epigallocatechin gallate (EGCG-the major phytochemical in green tea) on growth inhibition and behavior of human bladder carcinoma cells and to identify the altered signaling pathway(s) underlying the response to EGCG exposure. EGCG inhibited the in vitro growth of invasive bladder carcinoma cells with an IC(50) range of 70-87 microM. At a concentration of 20 microM, EGCG decreased the migratory potential of bladder carcinoma cells with concomitant activation of p42/44 MAPK and STAT3 and inactivation of Akt. Using biochemical inhibitors of MAPK/ERK, and siRNA to knockdown STAT3 and Akt, inhibition of migration was recorded associated with Akt but not MAPK/ERK or STAT3 signaling in bladder cells. In addition, EGCG downregulated N-cadherin in a dose-dependent manner where reduction in N-cadherin expression paralleled declining migratory potential. Continuous feeding of EGCG to mice prior to and during the establishment of bladder carcinoma xenografts in vivo revealed >50% reduction in mean final tumor volume (P </= 0.05) with no detectable toxicity. EGCG inhibited bladder carcinoma cell growth and suppressed the in vitro migration capacity of cells via downregulation of N-cadherin and inactivation of Akt signaling. Continuous administration of EGCG to mice revealed significant inhibition of tumor growth in vivo indicating a possible preventative role for green tea in bladder cancer. SN - 0730-2312 UR - https://www.unboundmedicine.com/medline/citation/17348027/The_green_tea_compound_____epigallocatechin_3_gallate_downregulates_N_cadherin_and_suppresses_migration_of_bladder_carcinoma_cells_ L2 - https://doi.org/10.1002/jcb.21299 DB - PRIME DP - Unbound Medicine ER -